10/27/2010. CKD in the United States. Management of The Patient With Chronic Kidney Disease. CKD Patients Are More Likely to Die Than Progress to ESRD

Size: px
Start display at page:

Download "10/27/2010. CKD in the United States. Management of The Patient With Chronic Kidney Disease. CKD Patients Are More Likely to Die Than Progress to ESRD"

Transcription

1 CKD in the United States Management of The Patient With Chronic Kidney Disease Paul J. Scheel, Jr., M.D., FASN Director,Division of Nephrology An estimated 26 million adults have CKD Many are unaware of their condition Prevalence is increasing : 14.5% : 16.8% Persons 60 years: 39.4% Risk factors Diabetes, CV disease, hypertension Mexican Americans, non-hispanic blacks CKD Patients Are More Likely to Die Than Progress to ESRD Management Goals Percentage of Patients 100% 90% 80% 70% 60% 50% 40% 5-Year Follow-up 74.8% 63.3% 64.2% 27.8% 6.6% 19.9% Event free Disenrolled RRT Died 1) Diagnose 2) Delay Progression 3) Treat Complications 4) Prepare For Renal Replacement Therapy 30% 20% 10% 0% 16.2% 10.3% 1.2% 1.0% 45.7% 14.9% 19.5% 24.3% 10.2% Stage 1 Stage 2 Stage 3 Stage 4 Adapted from: Keith DS et al. Arch Intern Med. 2004; 164: RRT = renal replacement therapy What is Chronic Kidney Disease (CKD)? CKD Stages Structural or functional abnormalities of the kidneys > 3 months, as manifested by either Kidney damage, with or without decreased glomerular filtration rate (GFR), defined by Pathologic abnormalities Markers of kidney damage in blood, urine, or imaging tests GFR < 60 ml/min/1.73m 2 Stage Description Kidney damage with normal GFR Kidney damage with mildly decreased GFR Moderately decreased GFR GFR ml/min/1.73 m 2 Prevalence ( 1000) Severely decreased GFR Kidney failure <15 or on dialysis Adapted from: Coresh J, et al. Am J Kidney Dis. 2003;41:

2 Serum Creatinine (mg/dl) Corresponding to GFR of 60 ml/min/1.73m 2 (Stage 3 CKD) Risk Factors for CKD Age (years) European-American African-American Men Women Men Women Using simplified (4-variable) MDRD equation CLINICAL FACTORS Diabetes mellitus Hypertension Autoimmune diseases Ui Urinary tract tobstruction/ ti infection/stones Family history of CKD/ESRD History of AKI Reduced kidney mass Low birth weight Exposure to certain medications/toxins SOCIOEPIDEMIOLOGIC FACTORS Older age Ethnicity: African American American Indian Hispanic Asian Pacific Islander Low income Lower educational level Determining GFR Serum creatinine is a POOR measure of kidney function Significant kidney disease may be present with nearnormal serum creatinine -- especially in older women Creatinine i clearance CCr = (140-age) x wt (in Kg) (x 0.85 in women) 72 x Cr 24-hour creatinine clearance Mean of 24-hour creatinine and urea clearances Determining GFR, cont d MDRD equation (estimated GFR in ml/min/1.73m 2 ) GFR=186 X (Cr) x (Age) x (0.742 if female) x (1.210 if African American) Not validated in Hispanic, certain other populations CKD-EPI equation (estimated GFR in ml/min/1.73m 2 ) GFR = 141 X min(scr/κ,1) α X max(scr/κ,1) X Age X [if female] X [if black] κ is 0.7 for females and 0.9 for males α is for females and for males Min indicates the minimum of Scr/κ or 1 Max indicates the maximum of Scr/κ or 1 Levey AS et al. Ann Intern Med. 2009;150: Available online: Calculated egfr is an estimate.. even with the new and improved version CKD-EPI True GFR could be > 55 ml/min.1.73m 2 egfr 45 ml/min/1.73m 2 = true GFR of ml/min/1.73m 2 or < 15 ml/min.1.73m 2 Botev R et. al. Clin J Am Soc Nephrol. 2009; 4: Available online: Levey AS et al. Ann Intern Med. 2009;150:

3 Screening for Microalbuminuria, Albuminuria or Proteinuria GFR, Proteinuria, and CKD Progression Standard urine dipsticks detect total protein > 30 mg/dl not sensitive enough for microalbuminuria screening Albumin-specific dipstick is useful for screening Untimed, random spot urine for ACR or protein/creatinine ratio (first morning void preferred) ACR: Normal<30mg/g; Mild mg/g; Heavy>300mg/g Hemmelgarn BR et al. JAMA. 2010;303(5): Available online at: Albuminuria, GFR, and Death GFR and albuminuria: egfr < ml/min/1.73m 2 Urine albumin > 10 mg/g creatinine Are INDEPENDENT predictors of all-cause and cardiovascular death Initial Assessment of Patient with Proteinuria and Elevated Creatinine History is the proteinuria and elevated creatinine new? Often old labs that can be helpful Rule out acute kidney injury (AKI) vs. CKD Recent events Diabetic vs. non-diabetic renal disease Is the proteinuria persistent Other urinalysis findings? Quantify proteinuria Chronic Kidney Disease Prognosis Consortium. Lancet. 2010;375(9731): Delay Progression Progression of CKD Can be modified Hypertension Albuminuria/proteinuria Dyslipidemia Hemoglobin A 1C Cannot be modified Age Ethnicity Gender Genes Smoking Dietary protein intake Anemia 3

4 Renoprotection Goals AASK: Effect of CCB vs ACEI on Renal Outcomes Blood pressure < 125/75 mmhg if proteinuria > 1 g/d < 130/80 mmhg if proteinuria < 1 g/d STILL CONTROVERSIAL!! Proteinuria < g/d Control lipid and blood glucose levels, stop smoking, lose weight Events per Person-yr 41% 44% 38% Peter son JC et al. Ann Intern Med. 1995;123: Adapted from: Agodoa LY et al. JAMA. 2001;285: Meta-analysis of the Effects of Dietary Protein Restriction on Rate of Decline in Renal Function Avoiding Acute Renal Injury 13 randomized controlled trials Mean follow-up 21.8 months Mean dietary protein intake (DPI) ~ mg/kg/d g vs. ~1-1.2 mg/kg/d g Protein restriction decreased rate of GFR decline by 0.53 ml/min/yr Volume depletion Iodinated radiographic contrast media Sodium phosphate bowel prep Nephrotoxic antibiotics NSAIDs Kasiske BL et al. Am J Kidney Dis. 1998;31(6): Lower BP Slows Decline in GFR Multiple Agents are Required to Achieve BP Goals /year) GFR (ml/min/ MAP (mmhg) /85 140/90 Untreated HTN Number of Agents Needed Bakris GL et al. Am J Kidney Dis. 2000; 36(3): Bakris GL, et al. Am J Kidney Dis. 2000; 36(3):

5 Our RAAS Blockade Tools ACE inhibitors ARBs Aldosterone receptor antagonists Direct renin inhibitors RAAS Blockade in Type II Diabetes Most placebo-controlled studies in type 2 DM have been in patients with either microalbuminuria or established nephropathy treated with ARB ARB and ACEi appear to be equivalent for microalbuminuria and proteinuria reduction No mortality benefit demonstrated RAAS=renin-angiotensin-aldosterone system Parving HH et al. NEJM.2001;345: Is More RAAS Blockade Better? Supra-high doses ACEi + ARB ACEior ARB + aldosterone receptor antagonist ACEi + ARB + aldosterone receptor antagonist The COOPERATE Trial Double-blind RCT of 336 pts with non-diabetic renal disease treated with ACEi or ARB or both ACEi + ARB resulted in greater reduction in proteinuria and fewer patients with doubling of serum creatinine or ESRD Similar BP control The only study to show improved CKD progression and ESRD outcomes with dual RAAS blockade Retracted by Lancet, October, 2009 Nakao, et al. (Lancet Jan 11;361(9352): ) Lancet Oct 10;374(9697):1226. Combined ACEi + ARB Treatment Summary No long-term studies showing improved renal outcomes (CKD progression, ESRD) Likewise for aldosterone receptor blockade No demonstrated mortality benefit in patients with CKD Risk > benefit, especially in patients at low risk for progression to ESRD In all patients on RAAS blockade, low Na + diet potentiates proteinuria reduction and BP management Use ACEi or ARB as first-line therapy for diabetics and nondiabetics with microalbuminuria or proteinuria Titrate doses to maximally reduce proteinuria Diuretics, low salt diet Consider dual therapy only in patients with high risk of CKD progression and significant proteinuria despite reasonably high doses of single ACEi or ARB ACEi+ ARB ACEi or ARB + spironolactone or eplerenone Add 2 nd agent in lowest doses Carefully monitor BP, egfr, K + 5

6 Treat Complications Metabolic Acidosis Metabolic Acidosis Secondary Hyperparathyroidism Anemia? Often becomes apparent at GFR < ml/min Higher protein diet more acidosis May contribute to bone disease, protein catabolism Maintain serum bicarbonate > 22 mmol/l Start with meq/kg per day Sodium bicarbonate tablets 325 mg (3.9 meq) or 650 mg (7.8 meq) tablets Sodium citrate solution 1 meq/ml Avoid if patient on aluminum phosphate binders Baking soda 54 meq/level tsp Vitamin D Consequences of PTH Elevation in Patients With CKD Decreased Vitamin D Receptors and Ca-Sensing Receptors PTH PTH PTH Bone Disease Bone Loss Pi Ca ++ 1,25 D Calcitriol Systemic Toxicity Cardiovascular Disease Phosphorous Calcium. Renal Failure 1(25)OH 2 D Decline and PTH Elevation as CKD Progresses Prevalence of Abnormalities of Mineral Metabolism, PTH in CKD 1(25)OH 2 D (ng/ml) CKD Stage 1 lower limit Stage 2 Stage 3 Stage 4 P<0.01 P< egfr (ml/min/1.73 m 2 ) N = 150. egfr = estimated glomerular filtration rate; ipth = intact parathyroid hormone. Martinez et al. Nephrol Dial Transplant. 1996;11(suppl 3): upper limit ipth (p pg/ml) % of Patients ipth >65 pg/ml Phosphorus >4.6 mg/dl Calcium <8.4 mg/dl CKD Stage 3 CKD Stages 4 and 5 > <20 (n = 61) (n = 117) (n = 230) (n = 396) (n = 355) (n = 358) (n = 204) (n = 93) Adapted from: Levin A et al. Kidney Int. 2007;71: egfr (ml/min/1.73 m 2 ) ipth = intact parathyroid hormone 6

7 CKD-MBD and Mortality CKD-Mineral Bone Density Testing All-cause and CV mortality increase 30-60% with each 1 mg/dl higher phosphorus level above normal Mortality impact of calcium and PTH levels in CKD patients not on dialysis is unknown No studies showing benefit of treatment Low phosphorous and calcium levels also associated with higher mortality Likely related to nutritional status CKD Stage Stage 3 Stage 4 Stage 5 Calcium, Phosphorus Every 6-12 months Every 3-6 months Every 1-3 months PTH Once then based on CKD progression Every 6-12 months Every 3-6 months 25(OH)D Once, then based on level and treatments Use CKD progression, presence or absence of abnormalities, treatment response and side effects to guide testing frequency Covic A et al. NDT. 2009;24: KDIGO Guideline. Kidney Int. 2009;76 (113):S1-S130. CKD-MBD Treatment Goals CKD-MBD Treatment Goals Use trends to guide therapy, rather than single level Bone density testing does not predict fracture risk so should not be used routinely for assessing CKD-MBD or guiding therapy Maintain calcium and phosphorus levels in reference ranges Treat 25(OH)D deficiency as in general population Cholecalciferol IU/d Ergocalciferol 10,000 IU weekly-50,000 IU monthly PTH goal unclear Treat with calcitriol or vitamin D analogue if progressively increasing despite correction of abnormal calcium, phosphorous, vitamin D levels In stage 5, maintain ipth 2-9 times upper reference level Calcimimetics not recommended in stage 3-5 CKD KDIGO Guideline. Kidney Int. 2009;76 (113):S1-S130. Uhlig K et al. Am J Kidney Dis. 2010;55(5): Phosphorus in Stage 3-5 CKD Dietary restriction to < mg/d Dietary protein intake ~ 1.2 g/kg/d Maintain caloric intake of kcal/kg/d Review diet: Food additives/preservatives Meat phosphorus absorption > seeds, nuts, legumes Highest P/protein ratio in many cheeses, milk, nondairy creamer Many soda, iced-tea have high phosphorus content Phosphorus Management in Stage 3-5 CKD Phosphate binders Aluminum hydroxide Least expensive Calcium carbonate Calcium acetate Sevelamer carbonate Lanthanum Most expensive Tolerability, interactions, and patient adherence also key considerations in binder selection 7

8 Calcium and Vitamin D in Stage 3-4 CKD Anemia Occurs Early in CKD and Worsens as Kidney Function Declines More opinion than evidence Maintain corrected total calcium within the normal range for the laboratory used, preferably toward the lower end (8.4 to 9.5 mg/dl; mmol/l) Supplement vitamin D2 if serum 25-(OH) vitamin D level <30 ng/ml (75 nmol/l) Ergocalciferol 50,000 U weekly-monthly depending on severity Treat with active oral vitamin D if serum 25(OH) vitamin D >30 ng/ml (75 nmol/l) and ipth is above target range Calcitriol: 0.25 mcg 3x/wk-daily ts (%) Patient Hgb 12 g/dl GFR (ml/min/1.73 m 2 ) Adapted from: McClellan et al. Curr Med Res Opin. 2004;20: Pathophysiology of Anemia in CKD Impact of Anemia in CKD Erythropoietin deficiency Iron deficiency Anemia of chronic investigation Vitamin deficiency (folate, B12) Renal osteodystrophy Infection/inflammation Other illness: malignancy, multiple myeloma, HIV, etc Decreased quality of life Increased: Morbidity and mortality risk Cardiovascular disorders LVH, angina, CHF, MI, stroke Physical and psychosocial impairments depression, cognitive impairment Hospitalization and length of hospital stay Rate of progression of CKD McClellan W et al. Curr Med Res Opin. 2004;20: Morreale A et al. Curr Med Res Opin. 2004;20(3): Kinchen KS et al. Ann Intern Med. 2002;137: Anemia is Associated with Higher Mortality Rate at each CKD Stage Anemia and Quality of Life ate n years) Mortality Ra (per 100 person Anemia Status GFR ml/min/1.73m2 Adapted from: Culleton, B. F. et al. Blood 2006; 107(10): Lefebvre et al. Curr Med Res Opinion. 2006; 22(10):

9 ESA Options Epoetin alfa Typically every 1-2 weeks, sometimes every 3-4 weeks Darbepoetin alfa Typically every 2-4 weeks Both given subcutaneously in CKD CHOIR Epoetin alfa in CKD Open label, RCT, N= 1432; mean study duration 16 months egfr ml/min/1.73m 2 Hgb < 11.0 g/dl High Hgb target: initially; changed 13.5 g/dl Low Hgb target: initially; changed 11.3 g/dl Singh AK et al. N Engl J Med. 2006;355(20): CHOIR Results 34% increased risk of composite outcome of death, MI, hospitalization for CHF, stroke (p = 0.03) No significant difference in % of patients requiring RRT Similar QOL measures TREAT Darbepoetin Alfa in CKD and Diabetes Double-blind placebo-controlled trial, N=4038 egfr ml/min/1.73m 2 Hgb < 11.0 g/dl Darbepoetin: adjusted to maintain Hgb ~13.0 g/dl Placebo: Darbepoetin only if/when Hgb < 9.0 g/dl Primary end points: time to composite of death or a CV event and time to composite of death or ESRD Singh AZ et al. N Engl J Med. 2006;355(20): Pfeffer MA et al. N Engl J Med ;361(21): TREAT Results No significant difference in cardiovascular composite endpoint Greater risk of stroke (~ 2X) in darbepoetin group No significant difference ESRD composite endpoint Similar QOL measures; some measures slightly better in darbepoetin group More hypertension and deaths due to cancer in patients with history of cancer in darbepoetin group FDA ALERT 2009 The dosing recommendations for anemic patients with chronic renal failure have been revised to recommend maintaining hemoglobin levels within g/dl. Quality of life claims in the previous labeling were removed, with the exception of improved exercise tolerance and functional ability for chronic renal failure patients The revised product labeling includes a strengthened Boxed Warning Pfeffer MA et al. N Engl J Med. 2009;361(21):

10 Cochrane Review 2010 Prepare For Renal Replacement Therapy Targeting higher hemoglobin levels in CKD increases risks for stroke, hypertension, and vascular access thrombosis and probably increases risks for death, serious cardiovascular events, and end stage renal disease. Modality Access Palmer SC et al. Ann Intern Med. 2010;153(1): When to Refer for Transplant Dialysis Options Pre-emptive transplant is best for many patients avoids dialysis altogether Living donor kidney outcomes are superior to deceased donor kidney outcomes Among living donors except identical twin not much difference among related and nonrelated donors Refer for transplant evaluation as egfr approaches ~ 20 ml/min Home HD Short daily Nocturnal PD Center HD Three times per week Nocturnal Self care Mange KC et al. Am J Transplant. 2003;3: Rao S et al. CJASN 2009;4: Dialysis: Early vs. Late Start RCT of > 800 patients with egfr ml/min Start HD (early start) or wait until egfr 5-7 ml/min (late start) 76% of late start group started with higher egfr due to symptoms or other indication Mean age 60 yrs No difference in survival, other outcomes, QOL Conclusion: OK to delay dialysis until GFR < 7.0 ml/min or other specific clinical indicators for the initiation of dialysis are present Cooper BA, et al. NEJM. 2010; Published Online June 27. Managing the Patient with CKD Summary 1. Assess GFR 2. Determine etiology; consider renal biopsy, etc. 3. Identify reversible factors Workup: complete H&P; cbc, electrolytes, bicarbonate, calcium, phosphate, albumin, urinalysis, SPEP/UPEP, assess proteinuria, renal ultrasound Approaching ESRD 1. Patient/family education 2. Chose RRT modality 3. Referral for transplant evaluation 4. Dialysis access Progressive CKD 1. Reduce progression 2. Manage comorbid conditions 3. Manage complications: BP - use ACEI/ARB, screen and treat hyperlipidemia, CA/phos/PTH, anemia; smoking cessation; preserve vessels; patient education 10

11 Questions? 11

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD Chronic Kidney Disease and the Electronic Health Record Duaine Murphree, MD Sarah M. Thelen, MD Definition of Chronic Kidney Disease (CKD) Defined by the National Kidney Foundation Either a decline in

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal

More information

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 Definition, Prevalence, Pathophysiology and Complications of CKD JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 KI supplements January 2013 Objectives of the course on CKD:

More information

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years

More information

Renal Disease in Type 2 Diabetes Mellitus

Renal Disease in Type 2 Diabetes Mellitus Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman

More information

OUTPATIENT MANAGEMENT OF CHRONIC KIDNEY DISEASE. Jeanie Park, MD MS Assistant Professor Renal Division Emory University School of Medicine

OUTPATIENT MANAGEMENT OF CHRONIC KIDNEY DISEASE. Jeanie Park, MD MS Assistant Professor Renal Division Emory University School of Medicine OUTPATIENT MANAGEMENT OF CHRONIC KIDNEY DISEASE Jeanie Park, MD MS Assistant Professor Renal Division Emory University School of Medicine Disclosures None Goals Background and staging Strategies to slow

More information

Diabetes and the Kidneys

Diabetes and the Kidneys Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease

More information

Guideline for Microalbuminuria Screening

Guideline for Microalbuminuria Screening East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network

More information

Nierfunctiemeting en follow-up van chronisch nierlijden

Nierfunctiemeting en follow-up van chronisch nierlijden Nierfunctiemeting en follow-up van chronisch nierlijden 12 Jan 2016 Patrick Peeters, M.D. Dept Nephrology Ghent University Hospital Plan of presentation 1/ Renal function determination: Measured GFR Estimated

More information

Chronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1

Chronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm (See NICE Clinical Guideline CG73 1 and Quality Standards 2 ) Who should have

More information

Prediction of Kidney Disease Progression in Patients with Diabetes

Prediction of Kidney Disease Progression in Patients with Diabetes Prediction of Kidney Disease Progression in Patients with Diabetes John Arthur, MD, PhD Medical University of South Carolina SEKDC Meeting September 8, 2012 Objectives Understand the importance of predicting

More information

Understanding diabetes Do the recent trials help?

Understanding diabetes Do the recent trials help? Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.

More information

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Introduction CKD의 정의와 egfr의 측정 CKD의 risk factor와 mechanism 한국의 CKD prevalence 와 prognosis CKD의 치료와

More information

Update in Contrast Induced Nephropathy

Update in Contrast Induced Nephropathy Update in Contrast Induced Nephropathy Yves Pirson Service de Néphrologie, Clin. Univ. St-Luc - UCL A 76-year-old man with - type 2 diabetes - CKD (ser. creat.: 1.8 mg/dl; GFR: 32) presents with angina

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT Diabetic nephropathy affects people with either type 1 or type 2 diabetes mellitus.

More information

Microalbuminuria: We are in the midst of an epidemic: the epidemic. So What s a Little Protein? Malcolm s diabetes. How much is too much?

Microalbuminuria: We are in the midst of an epidemic: the epidemic. So What s a Little Protein? Malcolm s diabetes. How much is too much? Focus on CME at the University of Saskatchewan Microalbuminuria: So What s a Little Protein? By Judith T. Klassen, BSc, MD, FRCPC University of Saskatchewan Practical Management of Common Medical Problems

More information

Albuminuria versus GFR as markers of diabetic CKD progression

Albuminuria versus GFR as markers of diabetic CKD progression Albuminuria versus GFR as markers of diabetic CKD progression KDIGO Controversies Conference: Diabetic Kidney Disease New Delhi, March 2012 Richard J MacIsaac PhD FRACP Director of Endocrinology & Diabetes,

More information

Medicare s Preventive Care Services. Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet

Medicare s Preventive Care Services. Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet s Preventive Care Services Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet What do the kidneys do? Your kidneys have important jobs to do in your body. Two of the kidneys most important jobs

More information

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering

More information

Hypertension and Diabetes

Hypertension and Diabetes Hypertension and Diabetes C.W. Spellman, D.O., Ph.D., FACOI Professor & Associate Dean Research Dir. Center Diabetes & Metabolic Disorders Texas Tech University Health Science Center Midland-Odessa, Texas

More information

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* 71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the

More information

Treatment Recommendations for CKD in Cats (2015)

Treatment Recommendations for CKD in Cats (2015) All treatments for chronic kidney disease (CKD) need to be tailored to the individual patient. The following recommendations are useful starting points for the majority of cats at each stage. Serial monitoring

More information

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.

More information

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Models of Chronic Kidney Disease Care and Initiation of Dialysis Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Early Crash Landings Talk Outline Pathways & Definitions Guideline recommendations

More information

Chronic Kidney Disease: Definitions and Optimal Management

Chronic Kidney Disease: Definitions and Optimal Management Chronic Kidney Disease: Definitions and Optimal Management Jai Radhakrishnan, MD, MS, MRCP, FACC, FASN Assoc Professor of Clinical Medicine Columbia University, New York, NY 7/3/2008 1 Objectives Definition

More information

CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE

CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE Outline I. Introduction II. Identifying Members with Kidney Disease III. Clinical Guidelines for Kidney Disease A. Chronic Kidney Disease B. End Stage Renal Disease

More information

survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156

survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156 introduction 152 < mortality in high- & low-risk patients 154 < predictors of mortality 156 < impact of anemia & dialysis therapy on mortality 158 < mortality in esrd patients with rare s 16 < expected

More information

UCSF Kidney Transplant Symposium 2012

UCSF Kidney Transplant Symposium 2012 UCSF Kidney Transplant Symposium 2012 Nutrition Fitness in Kidney Transplant Mary Ellen DiPaola, RD, CDE UCSF Outpatient Dietitian Goal of Nutrition Fitness for Transplant Nutritional guidance of pre-

More information

GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working

GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National

More information

The Stages of Chronic Kidney Disease and the Estimated Glomerular Filtration Rate

The Stages of Chronic Kidney Disease and the Estimated Glomerular Filtration Rate The Stages of Chronic Kidney Disease and the Estimated Glomerular Filtration Rate LAURENCE E. CARROLL, M.D., F.A.S.N. Hypertension Kidney Specialists INTRODUCTION The ability to assess kidney function

More information

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

HYPERTENSION ASSOCIATED WITH RENAL DISEASES RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein

More information

Calculating the stage of Renal Disease

Calculating the stage of Renal Disease Calculating the stage of Renal Disease When the Refresh Template/Check Labs button is depressed, the box next to MDRD, will be automatically checked. In order to use this in the calculation of the stage

More information

Chronic Kidney Disease (CKD) and Diet:

Chronic Kidney Disease (CKD) and Diet: Chronic Kidney Disease (CKD) and Diet: Assessment, Management, and Treatment Treating CKD Patients Who Are Not on Dialysis An Overview Guide for Dietitians Revised April 2015 Table of Contents I. About

More information

Diabetes and Your Kidneys

Diabetes and Your Kidneys American Kidney Fund reaching out giving hope improving lives Diabetes and Your Kidneys reaching out giving hope improving lives Diabetes: The #1 Cause of Kidney Failure Your doctor told you that you have

More information

Coding to be more efficient and accurate

Coding to be more efficient and accurate Why we need to code well! Coding to be more efficient and accurate Diabetes without Complication Diabetes with opthamologic or unspecified complication Diabetes with acute complication $1833 $2931 $3836

More information

Package nephro. February 23, 2015

Package nephro. February 23, 2015 Type Pack Title Biostatistics Utilities for Nephrology Version 1.1 Date 2015-01-31 Author Pack nephro February 23, 2015 Maintainer Set of functions to estimate the Glomerular

More information

Kidney Disease: Key Facts and Figures. September 2010

Kidney Disease: Key Facts and Figures. September 2010 Kidney Disease: Key Facts and Figures September 2010 ii Kidney Disease Key Facts and Figures Contents Introduction... 1 1 Kidney disease common definitions... 2 1.1 Chronic kidney disease... 2 1.2 Acute

More information

( Diabetic nephropathy) ( Microalbuminuria ) ( Macroalbuminuria )

( Diabetic nephropathy) ( Microalbuminuria ) ( Macroalbuminuria ) 2006 17 99-105 2006 20-40% ( ESRD ) 30 299 mg ( ) ( 300 mgday ) DCCBs ) dihydropyridine calcium channel blockers ( non- DCCBs ( -blockers ( diuretics ) 10%) 0.8 ( 60 mlmin per 1.73 m 2 30 mlmin per 1.73

More information

How To Know If Low Protein Diet Is Beneficial For Kidney Health

How To Know If Low Protein Diet Is Beneficial For Kidney Health Protein Intake and Diabetic Kidney Disease Robert C. Stanton Joslin Diabetes Center 1/Serum Creatinine Plot Low Protein Protects in Renal Ablation Model 24% Protein Diet 6% Protein Diet Right Nephrectomy

More information

20/03/2013. What is it and how did it disappear? What is it and how did it not disappear?

20/03/2013. What is it and how did it disappear? What is it and how did it not disappear? Calcium, phosphor and magnesium: pathophysiology, diagnosis, clinical management S. Van Laecke Ghent University Hospital BVN Core Curriculum Course 2013 What is it and how did it disappear? Miyamoto M

More information

William B. Schwartz Division of Nephrology Fellowship Training Program Curriculum

William B. Schwartz Division of Nephrology Fellowship Training Program Curriculum William B. Schwartz Division of Nephrology Fellowship Training Program Curriculum Consult/Transplant Servic Patient Care Take medical history Perform physical examination Urinalysis and sediment eval Interpret

More information

In many diabetes units, people with type

In many diabetes units, people with type Renal Microalbuminuria: Screening and management in type 2 diabetes Julia Arundale Introduction In many diabetes units, patients with type 1 or type 2 diabetes are screened for proteinuria. Screening for

More information

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases http://www.kidney-international.org & 2011 International Society of Nephrology The contribution of chronic kidney disease to the global burden of major noncommunicable diseases William G. Couser 1, Giuseppe

More information

Southern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care

Southern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care Southern Derbyshire Shared Care Pathology Guidelines AKI guidelines for primary care Contents: FLOW DIAGRAM: MANAGEMENT OF PATIENTS WITH AKI DETECTED IN PRIMARY CARE...2 FLOW DIAGRAM: POST AKI MANAGEMENT

More information

Estimated GFR Based on Creatinine and Cystatin C

Estimated GFR Based on Creatinine and Cystatin C Estimated GFR Based on Creatinine and Cystatin C Lesley A Stevens, MD, MS Tufts Medical Center, Tufts University School of Medicine Boston MA Chronic Kidney Disease-Epidemiology Collaboration UO1 DK 053869,

More information

Managing Anemia When You Are on Dialysis. Stage 5

Managing Anemia When You Are on Dialysis. Stage 5 Managing Anemia When You Are on Dialysis Stage 5 What is anemia? Anemia happens when your red blood cells are in short supply. Red blood cells carry oxygen from your lungs to all parts of your body, giving

More information

Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration

Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration Hiddo Lambers Heerspink Department of Clinical Pharmacology University Medical

More information

Risk Factors of chronic complex co-morbidities. Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy

Risk Factors of chronic complex co-morbidities. Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy Risk Factors of chronic complex co-morbidities Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy Statement 1 In real world practice (and in clinical trials), complex co-morbidities are the

More information

Making Sense of CKD. A Concise Guide for Managing Chronic Kidney Disease in the Primary Care Setting JULY 2014

Making Sense of CKD. A Concise Guide for Managing Chronic Kidney Disease in the Primary Care Setting JULY 2014 Making Sense of CKD A Concise Guide for Managing Chronic Kidney Disease in the Primary Care Setting JULY 2014 National Kidney Disease Education Program A program of the National Institutes of Health Table

More information

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.

More information

InDependent Diabetes Trust

InDependent Diabetes Trust InDependent Diabetes Trust Kidneys and Diabetes Updated July 2015 Registered Company Number 3148360 Registered Charity No 1058284 Contents Introduction Healthy Kidneys Kidney disease and diabetes The use

More information

Chronic Kidney Disease (CKD) Guideline

Chronic Kidney Disease (CKD) Guideline Chronic Kidney Disease (CKD) These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They are not intended to replace

More information

Chronic Kidney Disease and Diabetes

Chronic Kidney Disease and Diabetes Anyone with diabetes can get kidney disease. Diabetes and high blood pressure are the most common causes of kidney disease, and people often have both. Chronic (long term) kidney disease (CKD) caused by

More information

Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8)

Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) Adapted by Capital Health Plan Approved by Quality Improvement

More information

High Blood Pressure and Chronic Kidney Disease

High Blood Pressure and Chronic Kidney Disease High Blood Pressure and Chronic Kidney Disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney

More information

DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD

DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Elhami et al. SJIF Impact Factor 5.210 Volume 4, Issue 11, 1159-1166 Research Article ISSN 2278 4357 DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE

More information

High Blood Pressure and Kidney Disease

High Blood Pressure and Kidney Disease High Blood Pressure and Kidney Disease National Kidney and Urologic Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH The kidneys play a key

More information

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU Objectives: 1. To discuss epidemiology and presentation

More information

Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr

Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Stefan Pilz Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria Department

More information

Chronic Kidney Disease

Chronic Kidney Disease Page 1 of 6 Chronic Kidney Disease Chronic kidney disease (CKD) means that your kidneys are not working as well as they once did. Various conditions can cause CKD. Severity can vary but most cases are:

More information

Type 1 Diabetes ( Juvenile Diabetes)

Type 1 Diabetes ( Juvenile Diabetes) Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.

More information

PREOPERATIVE MANAGEMENT FOR BARIATRIC PATIENTS. Adrienne R. Gomez, MD Bariatric Physician St. Vincent Bariatric Center of Excellence

PREOPERATIVE MANAGEMENT FOR BARIATRIC PATIENTS. Adrienne R. Gomez, MD Bariatric Physician St. Vincent Bariatric Center of Excellence PREOPERATIVE MANAGEMENT FOR BARIATRIC PATIENTS Adrienne R. Gomez, MD Bariatric Physician St. Vincent Bariatric Center of Excellence BARIATRIC SURGERY Over 200,000 bariatric surgical procedures are performed

More information

Drug Treatment in Type 2 Diabetes with Hypertension

Drug Treatment in Type 2 Diabetes with Hypertension Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk

More information

Cardiovascular Risk in Diabetes

Cardiovascular Risk in Diabetes Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal Renal Function

Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal Renal Function JOURNAL OF INSURANCE MEDICINE Copyright E 2012 Journal of Insurance Medicine J Insur Med 2012;43:76 83 MORTALITY Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testing_serum_vitamin_d_levels 9/2015 2/2016 2/2017 2/2016 Description of Procedure or Service Vitamin D,

More information

IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2005

IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2005 IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2005 PATIENT IDENTIFICATION [Before completing please read instructions at the bottom of this page and on pages 4, 5 and 6]

More information

Kidney School is a program of the Medical Education Institute, Inc., a 501(c)(3) organization, 2002 2015. All Rights Reserved.

Kidney School is a program of the Medical Education Institute, Inc., a 501(c)(3) organization, 2002 2015. All Rights Reserved. A PROGRAM OF THE MEDICAL EDUCATION INSTITUTE, INC. Kidney School is a program of the Medical Education Institute, Inc., a 501(c)(3) organization, 2002 2015. All Rights Reserved. Module 7 Understanding

More information

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused

More information

High Blood pressure and chronic kidney disease

High Blood pressure and chronic kidney disease High Blood pressure and chronic kidney disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D. TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type

More information

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk Lynne T Braun, PhD, CNP, FAHA, FAAN Professor of Nursing, Nurse Practitioner Rush University Medical Center 2

More information

Diagnostic Assessments Relating to Renal Function: Why we do them? What do they mean? Mohamud Karim MD, FRCPC. Feb 27, 2015

Diagnostic Assessments Relating to Renal Function: Why we do them? What do they mean? Mohamud Karim MD, FRCPC. Feb 27, 2015 Diagnostic Assessments Relating to Renal Function: Why we do them? What do they mean? Mohamud Karim MD, FRCPC Feb 27, 2015 Acknowledgements: Previous presentor Why are Patients Referred? Renal Syndromes:

More information

Managing diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ)

Managing diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ) Managing diabetes in the post-guideline world Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ) Overview Pathogenesis of T2DM Aims of treatment The place of glycaemic control Strategies to improve glycaemic

More information

ASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM

ASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM ASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM Management of Traditional Cardiovascular Risk Factors in ESRD (Hypertension, Dyslipidemia, Glycemic Control) ROBERT D. TOTO, M.D. PROFESSOR OF MEDICINE

More information

World Kidney Day 11 March 2010: we must act on diabetic kidney disease

World Kidney Day 11 March 2010: we must act on diabetic kidney disease November 11, 2009 Diabetic kidney disease: Act now or pay later Robert C Atkins and Paul Zimmet For the 2010 International Society of Nephrology/International Federation of Kidney Foundations World Kidney

More information

Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology*

Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology* Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology* =Abstracts= Registry committee of Korean Society of Nephrology

More information

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing

More information

Hemodialysis: What You Need to Know

Hemodialysis: What You Need to Know Hemodialysis: What You Need to Know Healthy kidneys clean your blood and remove extra fluid in the form of urine. They also make hormones your body needs for some important functions. When kidney failure

More information

Identifying and treating long-term kidney problems (chronic kidney disease)

Identifying and treating long-term kidney problems (chronic kidney disease) Understanding NICE guidance Information for people who use NHS services Identifying and treating long-term kidney problems (chronic kidney disease) NICE clinical guidelines advise the NHS on caring for

More information

Diagnosis, classification and staging of chronic kidney disease

Diagnosis, classification and staging of chronic kidney disease Diagnosis, classification and staging of chronic kidney disease Date written: July 2012 Author: David Johnson DIAGNOSIS GUIDELINES a. We recommend that chronic kidney disease (CKD) be diagnosed in all

More information

SUPPLEMENT TO M A N A G E D. Care. Disease Management Opportunities for Chronic Kidney Disease

SUPPLEMENT TO M A N A G E D. Care. Disease Management Opportunities for Chronic Kidney Disease SUPPLEMENT TO Care M A N A G E D Implementing a Disease Management Program For Chronic Kidney Disease Based on a conference held in Philadelphia on April 22, 2003 HIGHLIGHTS Managing Chronic Kidney Disease

More information

HIGH BLOOD PRESSURE AND YOUR KIDNEYS

HIGH BLOOD PRESSURE AND YOUR KIDNEYS HIGH BLOOD PRESSURE AND YOUR KIDNEYS www.kidney.org About the Information in this Booklet Did you know that the National Kidney (NKF) Foundation offers guidelines and commentaries that help your healthcare

More information

Vitamin D. Sources of vitamin D

Vitamin D. Sources of vitamin D 1 has been in the news frequently this past year, including an article in The New York Times on November 16, 2009. So what is this vitamin? Why is it important? Most people have heard that vitamin D is

More information

DR. Trinh Thi Kim Hue

DR. Trinh Thi Kim Hue TYPE 2 DIABETES IN THE CHILD AND ADOLESCENT DR. Trinh Thi Kim Hue CONTENTS Definition Diagnosis Treatment Comorbidities and Complications Comorbidities and Complications Screening for T2D References DEFINITION

More information

The Hypertension Treatment Center

The Hypertension Treatment Center Patricia F. Kao MD MS Asst Professor, EVMS Nephrology & HTN April 26, 2014 The Hypertension Treatment Center I have no conflicts of interest to disclose Objectives Describe the role of Hypertension Treatment

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

Standard Medicare Part D* checklist

Standard Medicare Part D* checklist Standard Medicare Part D* checklist This checklist can help you receive Sensipar (cinacalcet) at the lowest possible cost. You can use this checklist if you: Have Standard Medicare Part D* prescription

More information

Chronic Kidney Disease: A New Classification and Staging System

Chronic Kidney Disease: A New Classification and Staging System Clinical Review Article Series Editor: Mark A. Perazella, MD, FACP Chronic Kidney Disease: A New Classification and Staging System Mark A. Perazella, MD, FACP Robert F. Reilly, MD Chronic kidney disease

More information

Position Statement Diabetic Nephropathy American Diabetes Association

Position Statement Diabetic Nephropathy American Diabetes Association Information obtained from the American Diabetes Association 2002 by the American Diabetes Association, Inc. Publication Date January 2002 in Diabetes Care 25:S85-S89, 2002 Edited by the Nephrology Department,

More information

High Blood Pressure and Chronic Kidney Disease. For People With CKD Stages 1 4

High Blood Pressure and Chronic Kidney Disease. For People With CKD Stages 1 4 High Blood Pressure and Chronic Kidney Disease For People With CKD Stages 1 4 National Kidney Foundation s Kidney Disease Outcomes Quality Initiative (NKF-KDOQI ) The National Kidney Foundation s Kidney

More information

Vitamin D Deficiency and Thyroid Disease. Theodore C. Friedman, M.D., Ph.D.

Vitamin D Deficiency and Thyroid Disease. Theodore C. Friedman, M.D., Ph.D. Vitamin D Deficiency and Thyroid Disease Theodore C. Friedman, M.D., Ph.D. Vitamin D deficiency and thyroid diseases Vitamin D is an important vitamin that not only regulates calcium, but also has many

More information

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized

More information

Renovascular Hypertension

Renovascular Hypertension Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension

More information

Chronic Kidney Disease - A Risk Factor and Symptoms

Chronic Kidney Disease - A Risk Factor and Symptoms Clinical features A Quick Guide to Evidence-Based Chronic Kidney Disease Care for the Primary Care Physician Chester H. Fox, MD 1 Vasu Voleti, MBBS 1 Linda S. Khan, PhD 1 Brian Murray, MD 1 Joseph Vassalotti,

More information

REHABILITATION AND SOCIAL ASPECTS IN HOLISTIC APPROACH OF CKD PATIENTS

REHABILITATION AND SOCIAL ASPECTS IN HOLISTIC APPROACH OF CKD PATIENTS REHABILITATION AND SOCIAL ASPECTS IN HOLISTIC APPROACH OF CKD PATIENTS 2 0 T H B U D A P E S T N E P H R O L O G Y S C H O O L Á G N E S H A R I S, K Á L M Á N P O L N E R HOW MUCH TROUBLE A CHRONIC DISESASE

More information

Testosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS

Testosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS Testosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS The faces of Low Testosterone What your patients are seeing Pharmacy Industry Testosterone

More information